Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity

References

• Norman FF, Comeche B, Chamorro S, et al. Update on the major imported protozoan infections in travelers and migrants. Future Microbiol. 2020;15:213–225.
   PubMed Web of Science ®Google Scholar
• Malaria. 2020. [accessed 2020 Aug 7]. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria.
   Google Scholar
• Muhindo MK, Kakuru A, Jagannathan P, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:1–8.
   PubMed Web of Science ®Google Scholar
• Kilonzi M, Minzi O, Mutagonda R, et al. Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether-lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children. Malar J. 2019;18:1–8.
   PubMed Web of Science ®Google Scholar
• Achan J, Talisuna AO, Erhart A, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.
   PubMed Web of Science ®Google Scholar
• Wahajuddin SP, Singh KSR, Raju A, et al. Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats. Malar J. 2011;10:293.
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265–278.
   PubMed Web of Science ®Google Scholar
• Ashley EA, Stepniewska K, Lindegårdh N, et al. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health. 2007;12(2):195–200.
   PubMed Web of Science ®Google Scholar
• Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol. 1998;46(6):553–561.
   PubMed Web of Science ®Google Scholar
• Gahoi S, Jain GK, Tripathi R, et al. Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. Colloids Surf B Biointerfaces. 2012;95:16–22.
   PubMed Web of Science ®Google Scholar
• Lefèvre G, Thomsen MS. Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Investig. 1999;18:467–480.
   Web of Science ®Google Scholar
• Shende P, Desai P, Gaud RS, et al. Engineering of microcomplex of artemether and lumefantrine for effective drug treatment in malaria. Artif Cells Nanomed Biotechnol. 2017;45(8):1597–1604.
   PubMed Web of Science ®Google Scholar
• Garg A, Bhalala K, Tomar DS. In-situ single pass intestinal permeability and pharmacokinetic study of developed lumefantrine loaded solid lipid nanoparticles. Int J Pharm. 2017;516:120–130.
   PubMed Web of Science ®Google Scholar
• Patel K, Sarma V, Vavia P. Design and evaluation of lumefantrine - oleic acid self nanoemulsifying ionic complex for enhanced dissolution. DARU. 2013;21(1):27.
   PubMedGoogle Scholar
• Parashar D, Aditya NP, Murthy RSR. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity. Drug Deliv. 2016;23(1):123–129.
   PubMed Web of Science ®Google Scholar
• Shakeel K, Raisuddin S, Ali S, et al. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery. J Liposome Res. 2019;29(1):35–43.
   PubMed Web of Science ®Google Scholar
• Trasi NS, Bhujbal SV, Zemlyanov DY, et al. Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach. Int J Pharm. 2020;2:100052.
   Google Scholar
• Wang Y, Wang C, Zhao J, et al. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability. J Colloid Interface Sci. 2017;485:91–98.
   PubMed Web of Science ®Google Scholar
• Junghanns J-UAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed. 2008;3(3):295–309.
   PubMed Web of Science ®Google Scholar
• Li M, Azad M, Davé R, et al. Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective. Pharmaceutics. 2016;8(2):17.
   PubMed Web of Science ®Google Scholar
• Malamatari M, Somavarapu S, Taylor KMG, et al. Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Expert Opin Drug Deliv. 2016;13(3):435–450.
   PubMed Web of Science ®Google Scholar
• Verma S, Kumar S, Gokhale R, et al. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406(1–2):145–152.
   PubMed Web of Science ®Google Scholar
• Salazar J, Ghanem A, Müller RH, et al. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. Eur J Pharm Biopharm. 2012;81(1):82–90.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):456–469.
   PubMed Web of Science ®Google Scholar
• Al Ashmawy AZG, Eissa NG, El Nahas HM, et al. Fast disintegrating tablet of doxazosin mesylate nanosuspension: preparation and characterization. J Drug Deliv Sci Technol. 2020. doi: 10.1016/j.jddst.2020.102210.
   Web of Science ®Google Scholar
• Sharma C, Desai MA, Patel SR. Effect of surfactants and polymers on morphology and particle size of telmisartan in ultrasound-assisted anti-solvent crystallization. Chem Pap. 2019;73(7):1685–1694.
   Web of Science ®Google Scholar
• Akrawi SH, Gorain B, Nair AB, et al. Development and optimization of naringenin-loaded chitosan-coated nanoemulsion for topical therapy in wound healing. Pharmaceutics. 2020;12(9):893.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm. 2009;370(1–2):202–209.
   PubMed Web of Science ®Google Scholar
• Kumbhar SA, Kokare CR, Shrivastava B, et al. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: in vitro and in vivo studies for brain targeting. Int J Pharm. 2020;586:119499.
   PubMedGoogle Scholar
• Choudhury H, Gorain B, Karmakar S, et al. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int J Pharm. 2014;460(1-2):131–143.
   PubMedGoogle Scholar
• Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193(4254):673–675.
   PubMed Web of Science ®Google Scholar
• Fidock DA, Rosenthal PJ, Croft SL, et al. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3(6):509–520.
   PubMed Web of Science ®Google Scholar
• Johnson JD, Dennull RA, Gerena L, et al. Assessment and continued validation of the malaria SYBR Green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51(6):1926–1933.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Banerjee S, Padhye S, et al. Parenterally administrable nano-micelles of 3, 4-difluorobenzylidene curcumin for treating pancreatic cancers. Colloids Surf B Biointerfaces. 2015; 132:138–145.
   PubMed Web of Science ®Google Scholar
• Dhumal RS, Biradar SV, Yamamura S, et al. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur J Pharm Biopharm. 2008;70(1):109–115.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Nokhodchi A, et al. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 2014;17(5):322–331.
   PubMed Web of Science ®Google Scholar
• Loh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10(4):255–274.
   Web of Science ®Google Scholar
• Ribeiro A, Figueiras A, Santos D, et al. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin. AAPS PharmSciTech. 2008;9(4):1102–1109.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu H, Tian B, et al. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 2012;13(1):295–304.
   PubMed Web of Science ®Google Scholar
• Jiang T, Han N, Zhao B, et al. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm. 2012;38(10):1230–1239.
   PubMed Web of Science ®Google Scholar
• Phale M, Pawar S, Patil P, et al. A simple and precise method for quantitative analysis of lumefantrine by planar chromatography. Pharm Methods. 2010;1(1):44–48.
   PubMedGoogle Scholar
• Patel SM, Doen T, Pikal MJ. Determination of end point of primary drying in freeze-drying process control. AAPS PharmSciTech. 2010;11(1):73–84.
   PubMed Web of Science ®Google Scholar
• Gitua J, Beck A, Rovers J. Quality and stability of artemether-lumefantrine stored under ambient conditions in rural Mali. Malar J. 2014;13: 474.
   PubMed Web of Science ®Google Scholar
• Wlodarski K, Sawicki W, Paluch KJ, et al. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil. Eur J Pharm Sci. 2014;62:132–140.
   PubMed Web of Science ®Google Scholar
• Cheow WS, Kiew TY, Yang Y, et al. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles. Mol Pharm. 2014;11(5):1611–1620.
   PubMedGoogle Scholar
• Lindfors L, Forssén S, Skantze P, et al. Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations. Langmuir. 2006;22(3):911–916.
   PubMed Web of Science ®Google Scholar
• Gommes CJ. Ostwald ripening of confined nanoparticles: chemomechanical coupling in nanopores. Nanoscale. 2019;11(15):7386–7393.
   PubMed Web of Science ®Google Scholar
• Patel VR, Agrawal YK. Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res. 2011;2(2):81–87.
   PubMedGoogle Scholar
• Lindfors L, Skantze P, Skantze U, et al. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. Langmuir. 2006;22(3):906–910.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng Y, Zhang L, et al. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3):1126–1141.
   PubMed Web of Science ®Google Scholar
• Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24:3.
   PubMedGoogle Scholar
• Kathpalia H, Salunkhe S, Juvekar S. Formulation of gastroretentive sustained release floating in situ gelling drug delivery system of solubility enhanced curcumin-soy lecithin complex. J. Drug Deliv Sci Technol. 2019;53:101205.
   Web of Science ®Google Scholar
• Sajeev Kumar B, Saraswathi R, Venkates Kumar K, et al. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Drug Deliv. 2014;21(3):173–184.
   PubMed Web of Science ®Google Scholar